Clinical Trials Core
Clinical Trials Core
批准号:
8530577
负责人:
Jeff M Michalski
金额:
$0.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Adverse eventAdvisory CommitteesAreaBudgetsCancer CenterCancer Center Support GrantClinical ResearchClinical TrialsCommunicationComplexConsent FormsContinuing EducationContractsDataData CollectionDatabasesDevelopmentDevelopmental Therapeutics ProgramDiagnosticElectronicsEligibility DeterminationEnrollmentFacultyFundingFunding AgencyGoalsGrowthHematopoieticHumanInstitutional Review BoardsInternetLaboratoriesLaboratory FindingLeadershipLogisticsMalignant NeoplasmsMarketingMethodsMissionMolecularMonitorPatient CarePatientsPhasePhysiciansPlayPreparationProcessProtocols documentationRadiationRadiopharmaceuticalsRecombinant DNARegulatory AffairsReportingResearchResearch ActivityResearch DesignResearch PersonnelResearch SupportResource SharingRoleSafetyScienceSeriesServicesTechnologyTrainingTraining and EducationTranslatingTranslational ResearchUnited States National Institutes of HealthWorkanticancer researchbasecancer genomicscancer health disparitydata managementhuman subjectindexinginstitutional biosafety committeemalignant breast neoplasmmembernovelprogramsprotocol developmentquality assurancetool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The SCC Clinical Trials Core (CTC) provides critical support to Siteman Cancer Center investigators for
cancer clinical research. The goal of the CTC Is to facilitate translational research by providing access to an
effective, efficient, and economical clinical research team highly specialized in cancer research.
Comprehensive services are available through the CTC for all aspects of protocol development, regulatory
submissions, study coordination, data management and education and training, all of which will be essential
for the SCC's growth in translational clinical research.
¿ Protocol development staff provide expertise and research assistance in the following areas: study
design; protocol and consent form development and editing; facilitating biostatistical support;
development of data collection methods; and facilitating development of study-defined database tools.
¿ Regulatory services include management of all regulatory affairs. These services include protocol
submission and processing; trial close-out; Protocol Review & Monitoring Committee (PRMC), Quality
Assurance & Safety Monitoring Committee (QASMC), and Human Studies Committee (HSC, WU IRB)
submissions; assembling IND applications to the FDA ; and interaction with other regulatory agencies
and institutional offices [NIH Recombinant DNA Advisory Committee (RAC), Institutional Biosafety
Committee (IBC)), Radiation Safety Committee (RSC); Radioactive Drug Research Committee (RDRC),
Centerfor Clinical Studies (CCS), Office of Technology Management (OTM)]
¿ Studv coordination includes services in all aspects of trial conduct and data management, including but
not limited to: trial logistics assessment; eligibility verification; study coordination; data collection; record
retention; data safety and monitoring reporting; audit and monitoring preparation; adverse event
assessment and reporting; and data summary completion for analysis.
¿ Education and Training of the Clinical Trials staff is provided by an aggressive orientation, training, and
tracking program. Additionally, the program provides continuing education opportunities to the staff.
This service is currently available to the CTC staff on an ongoing basis. The CTC also assists
investigators with identifying potential funding sources, budget and contract development and other
study-related activities, and provides clinical trials tools (e.g., SCC protocol Index, Web postings and
electronic access to protocol documents).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Radium-223 Combination Therapy Space; Improving Response and Clarifying Toxicities
-
批准号:10577850
-
项目类别:
-
资助金额:$42.9万
-
财政年份:2020
-
负责人:Jeff M Michalski
-
依托单位:
The Radium-223 Combination Therapy Space; Improving Response and Clarifying Toxicities
-
批准号:10356921
-
项目类别:
-
资助金额:$42.53万
-
财政年份:2020
-
负责人:Jeff M Michalski
-
依托单位:
The Radium-223 Combination Therapy Space; Improving Response and Clarifying Toxicities
-
批准号:9973321
-
项目类别:
-
资助金额:$51.58万
-
财政年份:2020
-
负责人:Jeff M Michalski
-
依托单位:
Clinical Trials Core
-
批准号:8181226
-
项目类别:
-
资助金额:$31.33万
-
财政年份:2010
-
负责人:Jeff M Michalski
-
依托单位:
Advanced Technology QA Center
-
批准号:7919183
-
项目类别:
-
资助金额:$161.85万
-
财政年份:2009
-
负责人:Jeff M Michalski
-
依托单位:
Core--Clinical Trials Facility
-
批准号:6998206
-
项目类别:
-
资助金额:$22.87万
-
财政年份:2004
-
负责人:Jeff M Michalski
-
依托单位:
Advanced Technology QA Center
-
批准号:8100298
-
项目类别:
-
资助金额:$161.73万
-
财政年份:1999
-
负责人:Jeff M Michalski
-
依托单位:
Advanced Technology QA Center
-
批准号:8690240
-
项目类别:
-
资助金额:$128.78万
-
财政年份:1999
-
负责人:Jeff M Michalski
-
依托单位:
Advanced Technology QA Center
-
批准号:7884497
-
项目类别:
-
资助金额:$171.6万
-
财政年份:1999
-
负责人:Jeff M Michalski
-
依托单位:
Advanced Technology QA Center
-
批准号:7664619
-
项目类别:
-
资助金额:$171.6万
-
财政年份:1999
-
负责人:Jeff M Michalski
-
依托单位:
Advanced Technology QA Center
-
批准号:8467802
-
项目类别:
-
资助金额:$161.77万
-
财政年份:1999
-
负责人:Jeff M Michalski
-
依托单位:
Advanced Technology QA Core Services Plan
-
批准号:8748246
-
项目类别:
-
资助金额:$15.06万
-
财政年份:1997
-
负责人:Jeff M Michalski
-
依托单位:
Core--Clinical Trials Facility
-
批准号:7497937
-
项目类别:
-
资助金额:$63.03万
-
财政年份:--
-
负责人:Jeff M Michalski
-
依托单位:
Core--Clinical Trials Facility
-
批准号:7287736
-
项目类别:
-
资助金额:$24.26万
-
财政年份:--
-
负责人:Jeff M Michalski
-
依托单位:
Clinical Trials Core
-
批准号:8705891
-
项目类别:
-
资助金额:$33.53万
-
财政年份:--
-
负责人:Jeff M Michalski
-
依托单位:
Core--Clinical Trials Facility
-
批准号:7117730
-
项目类别:
-
资助金额:$23.55万
-
财政年份:--
-
负责人:Jeff M Michalski
-
依托单位:
Clinical Trials Core
-
批准号:8380319
-
项目类别:
-
资助金额:$34.46万
-
财政年份:--
-
负责人:Jeff M Michalski
-
依托单位:
Clinical Trials Core
-
批准号:8520221
-
项目类别:
-
资助金额:$33.06万
-
财政年份:--
-
负责人:Jeff M Michalski
-
依托单位:
Clinical Trials Core
-
批准号:8312684
-
项目类别:
-
资助金额:$29.69万
-
财政年份:--
-
负责人:Jeff M Michalski
-
依托单位:
Core--Clinical Trials Facility
-
批准号:7674618
-
项目类别:
-
资助金额:$60.15万
-
财政年份:--
-
负责人:Jeff M Michalski
-
依托单位:
海外基金